Providence Saint Joseph Medical Center - Video Presentation
 
 
My Online CME Login Username: Password: Register >
Login Help >
 
 
Get the Flash Player to see this player.
Click the button to view the videos in full screen
Targeted Temperature Management


This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)TM.
7/21/2010
Steven Taback, MD.
User
Hope Conference Room C
Video List
Advanced Clinical Integration and Accountable Care

This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)TM.
07/13/2010
Advisory Board Accountable Care Initiation Hogan Marren, Ltd, Other.
Presenter
Hope Conference Center
Prevention and Treatment of Vitamin D Deficiency: Endocrinology Perspective
YAROSLAV GOFNUNG, M.D.
DEPARTMENT OF MEDICINE, PSJMC
MODERATOR: Paola Tempesti, M.D.; Department of Medicine, PSJMC
FACULTY DISCLOSURE: According to CMA guidelines for faculty/planner disclosure of commercial support, we are required to announce the following:
Dr. Gofnung states he has no disclosures. Dr. Tempesti states she has stock in Bristol Myers Squibb.

OBJECTIVES At the end of the presentation, attendees will be able to:

  • identify who is at risk for Vitamin D deficiency and recognize the signs and symptoms.
  • conduct an appropriate work-up for Vitamin D status and interpret results.
  • incorporate into practice the latest recommendations for prevention and treatment of Vitamin D deficiency.
  • identify cultural/linguistic factors that impact the epidemiology, incidence, diagnosis, treatment, clinical course, and/or long-term outcomes of Vitamin D deficiency.

This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)TM.
06/29/2010
Yaroslav Gofnung, MD.
Staff
Hope Conference Center
Envenomations: Snakes, Spiders and other Critters
CYRUS RANGAN, M.D.
DIRECTOR, TOXICOLOGY AND ENVIRONMENTAL ASSESSMENT BUREAU LOS ANGELES DEPARTMENT OF PUBLIC HEALTH
MODERATOR: Sheldon Kishineff, MD, Pediatric Department, PSJMC
FACULTY DISCLOSURE: According to CMA guidelines for faculty/planner disclosure of commercial support, we are required to announce the following:
Dr. Rangan states he has no disclosures. Dr. Kishineff states he has no disclosures.

OBJECTIVES At the end of the presentation, attendees will be able to:

  • identify areas inhabited by snakes, spiders and other critters and the risks involved in critter/human encounters.
  • describe patients at risk for adverse reactions to bites from snakes, spiders and other critters.
  • develop a clinical approach for preventing and managing envenomations.
  • determine the link between envenomations, adverse outcomes and socio-cultural factors.

    This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)™
    This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)TM.

06/15/2010
Cyrus Rangan, MD.
Presenter
Hope Conference Center
American Recovery and Reinvestment Act
DOUGLAS JONES
DIR., INFORMATION SYSTEMS, PROVIDENCE HEALTH &SERVICES, CA REGION
MODERATOR: Raffi Mesrobian, MD; Vice-Chief of Staff, PSJMC
FACULTY DISCLOSURE: According to CMA guidelines for faculty/planner disclosure of commercial support, we are required to announce the following: Mr. Jones states he has no disclosures. Dr. Mesrobian states he has no disclosures.

OBJECTIVES
At the end of the presentation, attendees will be able to:

  • cite the provisions of the ARRA related to HIT and EMR and determine the potential impact on hospitals and physicians in California.
  • discuss how physicians can best prepare for adoption of HIT and receive federal subsidy for implementation of “meaningful use” of EMR.
  • determine how PH&S California Region is assisting in the HIT alignment of physician groups and hospitals.
  • identifycultural/linguistic factors such as computer literacy that impact the long-term outcomes of HIT adoption.


This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)TM.

06/03/2010
Douglas Jones, Other.
Staff
Hope Conference Center
 
Copyright © 1997-2007 Providence Health System | About your Privacy | Please read our Disclaimer | Site Map